(Q40442249)

English

Secretion of proinflammatory cytokines and chemokines during amphotericin B exposure is mediated by coactivation of toll-like receptors 1 and 2.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

20 September 2017

Secretion of proinflammatory cytokines and chemokines during amphotericin B exposure is mediated by coactivation of toll-like receptors 1 and 2. (English)

1 reference

Europe PubMed Central

20 September 2017

toll-like receptor

0 references

1 reference

based on heuristic

inferred from title

author name string

Raymund R Razonable

1

1 reference

Europe PubMed Central

20 September 2017

Martin Henault

2

1 reference

Europe PubMed Central

20 September 2017

Linda N Lee

3

1 reference

Europe PubMed Central

20 September 2017

Carmen Laethem

4

1 reference

Europe PubMed Central

20 September 2017

Paul A Johnston

5

1 reference

Europe PubMed Central

20 September 2017

Harold L Watson

6

1 reference

Europe PubMed Central

20 September 2017

Carlos V Paya

7

1 reference

Europe PubMed Central

20 September 2017

language of work or name

0 references

publication date

1 April 2005

1 reference

Europe PubMed Central

20 September 2017

Antimicrobial Agents and Chemotherapy

1 reference

Europe PubMed Central

20 September 2017

49

1 reference

Europe PubMed Central

20 September 2017

4

1 reference

Europe PubMed Central

20 September 2017

1617-1621

1 reference

Europe PubMed Central

20 September 2017

Streptomyces nodosus sp. n., the amphotericin-producing organism

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1068636

22 September 2017

Importance of extra- and intracellular domains of TLR1 and TLR2 in NFkappa B signaling

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1068636

22 September 2017

The antifungal drug amphotericin B promotes inflammatory cytokine release by a Toll-like receptor- and CD14-dependent mechanism

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1068636

22 September 2017

Amphotericin B and its new formulations: pharmacologic characteristics, clinical efficacy, and tolerability.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1068636

22 September 2017

Review of comparative studies between conventional and liposomal amphotericin B (Ambisome) in neutropenic patients with fever of unknown origin and patients with systemic mycosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1068636

22 September 2017

The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between toll-like receptors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1068636

22 September 2017

A randomized comparison of liposomal versus conventional amphotericin B for the treatment of pyrexia of unknown origin in neutropenic patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1068636

22 September 2017

Pharmacologic modulation of interleukin-1 expression by amphotericin B-stimulated human mononuclear cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1068636

22 September 2017

Amphotericin B activation of human genes encoding for cytokines

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1068636

25 September 2017

Comparative internalization and recycling of different amphotericin B formulations by a macrophage-like cell line

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1068636

25 September 2017

Do variations in molecular structure affect the clinical efficacy and safety of lipid-based amphotericin B preparations?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1068636

25 September 2017

Amphotericin B-phospholipid interactions responsible for reduced mammalian cell toxicity

1 reference

https://pubmed.ncbi.nlm.nih.gov/15793154

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Infusion-related toxicity of three different amphotericin B formulations and its relation to cytokine plasma levels

1 reference

https://pubmed.ncbi.nlm.nih.gov/15793154

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recognition of lipopeptides by Toll-like receptors

1 reference

https://pubmed.ncbi.nlm.nih.gov/15793154

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Liposomal amphotericin B is toxic to fungal cells but not to mammalian cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/15793154

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1128/AAC.49.4.1617-1621.2005

1 reference

Europe PubMed Central

20 September 2017

release_kuxxsyo45rc2fbqotgxf25hxpe

1 reference

https://api.fatcat.wiki/v0/release/kuxxsyo45rc2fbqotgxf25hxpe

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

20 September 2017

1 reference

Europe PubMed Central

20 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40442249&oldid=1837924988"